MedPath

A COMPARISON OF EFFICACY AND SAFETY OF KAYA KALPA VATI AND SEABUCK THORN OIL WITH ORAL METHOTREXATE AND TOPICAL STEROID IN CHRONIC PLAQUE PSORIASIS

Phase 4
Conditions
Health Condition 1: L400- Psoriasis vulgaris
Registration Number
CTRI/2020/06/025658
Lead Sponsor
ational Institute of Medical Sciences and Research Centre
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Patient with chronic plaque psoriasis.

2.Psoriasis of both sex and age group more than 18 years.

3.All newly diagnosed and old cases of psoriasis.

4.Patients with PASI(psoriasis area severity index) score above10-12.

5.Patients with involvement of >10% body surface area.

Exclusion Criteria

1. Patient who do not give consent for the study.

2. Patient on any therapy of psoriasis for past 3 months.

3.Patient having any other chronic debilitating diseases or other chronic skin disorders.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Reduction in PASI score <br/ ><br>Improvement in DLQITimepoint: 8weeks
Secondary Outcome Measures
NameTimeMethod
Reduction in PASI score <br/ ><br>Improvement in DLQITimepoint: 16 weeks
© Copyright 2025. All Rights Reserved by MedPath